Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥502.01 Million ≈ $73.46 Million USD) by net assets (CN¥6.75 Billion ≈ $987.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Nanjing King-friend Biochemical Pharmace carry for a breakdown of total debt and financial obligations.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Triputra Agro Persada Tbk PT JK:TAPG	0.103x
Mtar Technologies Limited NSE:MTARTECH	0.016x
V2X Inc NYSE:VVX	0.037x
Empresas Cablevisión S.A.B. de C.V MX:CABLECPO	0.185x
Partner TA:PTNR	0.068x
Aker Solutions ASA OL:AKSO	0.124x
Ströer SE & Co. KGaA F:SAX	0.231x
Nanjing Hanrui Cobalt Co Ltd SHE:300618	-0.086x

Annual Cash Flow Conversion Efficiency for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Nanjing King-friend Biochemical Pharmace worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.49 Billion ≈ $949.42 Million	CN¥1.50 Billion ≈ $219.68 Million	0.231x	-17.14%
2023-12-31	CN¥5.80 Billion ≈ $848.50 Million	CN¥1.62 Billion ≈ $236.94 Million	0.279x	+189.21%
2022-12-31	CN¥6.17 Billion ≈ $902.45 Million	CN¥595.45 Million ≈ $87.13 Million	0.097x	-23.70%
2021-12-31	CN¥5.40 Billion ≈ $790.59 Million	CN¥683.63 Million ≈ $100.04 Million	0.127x	+183.74%
2020-12-31	CN¥3.74 Billion ≈ $547.95 Million	CN¥-565.85 Million ≈ $-82.80 Million	-0.151x	+46.05%
2019-12-31	CN¥3.00 Billion ≈ $439.59 Million	CN¥-841.38 Million ≈ $-123.12 Million	-0.280x	-1187.25%
2018-12-31	CN¥2.42 Billion ≈ $354.28 Million	CN¥62.37 Million ≈ $9.13 Million	0.026x	+122.54%
2017-12-31	CN¥2.05 Billion ≈ $300.31 Million	CN¥-234.59 Million ≈ $-34.33 Million	-0.114x	+47.60%
2016-12-31	CN¥1.31 Billion ≈ $192.37 Million	CN¥-286.79 Million ≈ $-41.97 Million	-0.218x	-273.64%
2015-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥137.28 Million ≈ $20.09 Million	0.126x	-27.47%
2014-12-31	CN¥1.03 Billion ≈ $150.99 Million	CN¥178.74 Million ≈ $26.16 Million	0.173x	-9.03%
2013-12-31	CN¥1.02 Billion ≈ $149.02 Million	CN¥193.91 Million ≈ $28.38 Million	0.190x	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.15 Billion

CN¥14.70 Billion CNY

Market Cap Rank

#6068 Global

#1341 in China

Share Price

CN¥9.10

Change (1 day)

+0.00%

52-Week Range

CN¥9.03 - CN¥11.94

All Time High

CN¥33.62